Member of the Association of American Physicians
His main research concerns Immunology, Virology, Viral load, Internal medicine and Acquired immunodeficiency syndrome. His work is connected to Immune system, T cell, CD8, Viral replication and Viremia, as a part of Immunology. His study looks at the relationship between Virology and topics such as Vorinostat, which overlap with Prostratin.
His Viral load study also includes fields such as
His scientific interests lie mostly in Immunology, Virology, Viral load, Internal medicine and T cell. His Immunology research incorporates elements of Cytotoxic T cell and Acquired immunodeficiency syndrome. Steven G. Deeks interconnects Antibody and Antiretroviral therapy in the investigation of issues within Virology.
In his work, Allele is strongly intertwined with Human leukocyte antigen, which is a subfield of Viral load. His research integrates issues of Gastroenterology, Oncology and Cardiology in his study of Internal medicine. In his study, Disease is inextricably linked to Inflammation, which falls within the broad field of Immune system.
Steven G. Deeks spends much of his time researching Virology, Immunology, Internal medicine, T cell and Antiretroviral therapy. His Virology study which covers In vivo that intersects with Cd4 t cell. His Immunology study often links to related topics such as Peripheral blood mononuclear cell.
His Internal medicine research includes elements of Placebo, Acquired immunodeficiency syndrome and Oncology. His T cell study integrates concerns from other disciplines, such as Virus latency, Viral replication, CD8, Cell biology and Epigenetics. Steven G. Deeks has included themes like Interquartile range and Viral load in his Cohort study.
Steven G. Deeks mainly focuses on Immunology, Virology, T cell, Cytotoxic T cell and Antiretroviral therapy. The concepts of his Immunology study are interwoven with issues in Fibrosis and Receptor. The Virology study combines topics in areas such as Chromatin, DNA, Proviral dna, Provirus and Antibody.
His T cell research incorporates elements of Virus latency, In vitro, Effector, Cell biology and Epigenetics. Steven G. Deeks combines subjects such as Acquired immune system, CD8 and Immune system with his study of Cytotoxic T cell. His Antiretroviral therapy research is multidisciplinary, relying on both After treatment, Viral load and Intensive care medicine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study
Daniel D. Murray;Kazuo Suzuki;Matthew Law;Jonel Trebicka.
PLOS ONE (2015)
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
Jason M. Brenchley;David A. Price;Timothy W. Schacker;Tedi E. Asher.
Nature Medicine (2006)
Effect of early versus deferred antiretroviral therapy for HIV on survival.
Mari M. Kitahata;Stephen J. Gange;Alison G. Abraham;Barry Merriman.
The New England Journal of Medicine (2009)
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation
Pereyra F;Jia X;McLaren Pj.
The end of AIDS: HIV infection as a chronic disease
Steven G Deeks;Sharon Ruth Lewin;Sharon Ruth Lewin;Diane V Havlir.
The Lancet (2013)
HIV Infection, Inflammation, Immunosenescence, and Aging
Steven G. Deeks.
Annual Review of Medicine (2011)
HIV-1 protease inhibitors. A review for clinicians.
Steven G. Deeks;Mark Smith;Mark Holodniy;James O. Kahn.
Plasma Levels of Soluble CD14 Independently Predict Mortality in HIV Infection
Netanya Sandler;Handan Wand;Annelys Roque;Matthew G Law.
The Journal of Infectious Diseases (2011)
Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load.
Steven G. Deeks;Christina M. R. Kitchen;Lea Liu;Hua Guo.
Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia.
Steven G. Deeks;Terri Wrin;Teri Liegler;Rebecca Hoh.
The New England Journal of Medicine (2001)
Current Opinion in HIV and AIDS
(Impact Factor: 4.061)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: